AI Summary
This study focuses on the use of doxorubicin-loaded ultrasmall gold nanoparticles (1.5 nm) for brain tumor therapy. The research also evaluates the biodistribution of these nanoparticles. The potential outcomes could include improved targeted therapy for brain tumors with reduced side effects compared to traditional chemotherapy. This research is significant for the field of oncology and nanomedicine, as it explores a novel approach to treating brain tumors.